Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

19.28
Delayed Data
As of May 28
 -0.33 / -1.68%
Today’s Change
9.38
Today|||52-Week Range
20.75
+60.13%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 27.00 and a low estimate of 7.00. The median estimate represents a +3.73% increase from the last price of 19.28.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$15.1M
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.94%
 
 
 
 
 
 
Growthannually 70.26%
 
 
 
 
 
 

Sales

Growthquarterly 76.79%
 
 
 
 
 
 
Growthannually 113.89%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account